|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 18, 2016 ) Biosimilars are defined as the follow-on versions of original biological medicines. These are separately developed after the patent protecting the original product has expired. Biosimilars are intended to have the same MOA as original biological drugs and are designed to treat the same diseases as the innovators product. They have many similarities, but are not identical to, the reference biopharmaceutical product.
Technavios analysts forecast the global biosimilars market to grow at a CAGR of 55.52% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global biosimilars market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sale of products such as somatropin, erythropoietin, colony-stimulating factors (CSF), interferons, interleukins, insulin and insulin analogs, follicle stimulating hormones (FSH), monoclonal antibodies (mAbs), and low molecular weight heparins (LMWH).
To Get Sample Copy of Report visit @ http://www.researchmoz.us/enquiry.php?type=S&repid=775744
The market is divided into the following segments based on geography:
Americas
APAC
EMEA
New report, Global Biosimilars Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
Biocon
Celltrion
Dr. Reddy's Laboratories
Hospira
Sandoz
STADA
Teva Pharmaceuticals
Other prominent vendors
3SBio
Accord Healthcare
AET Biotech
Allergan
Alvartis Pharma
Amega Biotech
Amgen
Apotex
Aspen
AstraZeneca
Aurobindo Pharma
Baxter
Bharat Serums
Bio Sidus
Biogen
Bionovis
Bioton
BioXpress Therapeutics
Boehringer Ingelheim
Boston Oncology
Cipla
Coherus Biosciences
Daiichi Sankyo
Emcure Pharmaceuticals
Gedeon Richter
GeneScience Pharmaceuticals
GSK
Hetero Drugs
iBio
Intas Pharmaceuticals
JCR Pharmaceuticals
LG Lifesciences
Lonza
Merck
Mitsubishi Tanabe Pharma
Momenta Pharmaceuticals
Mylan
Natco Pharma
Novartis
Pfenex
Pfizer
Ranbaxy Laboratories
Roche Holding
Samsung Biologics
Sanofi
Synthon
Wockhardt
Zydus Cadila Healthcare
Make an Enquiry of this report @ http://www.researchmoz.us/enquiry.php?type=E&repid=775744
Market driver
Rise in number of patent expiries
For a full, detailed list, view our report
Market challenge
Physicians reluctance to prescribe biosimilars
For a full, detailed list, view our report
Market trend
Emergence of biosimilars
For a full, detailed list, view our report
Key questions answered in this report
What will the market size be in 2020 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Researchmoz Global Pvt.Ltd
Researchmoz
+1-518-621-2074
sales@researchmoz.us
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
